|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Design Therapeutics, Inc. (DSGN) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
55,620,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Design Therapeutics is a preclinical-stage biopharmaceutical company pioneering GeneTAC™ molecules, which are a class of small-molecule gene targeted chimera therapeutic candidates that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Co.'s product candidate is in Friedreich ataxia, its second GeneTAC program is in myotonic dystrophy type-1, and it is also advancing its GeneTAC portfolio to address other serious nucleotide repeat-driven monogenic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
28,265 |
28,265 |
2,296,265 |
4,118,715 |
| Total Buy Value |
$104,605 |
$104,605 |
$5,555,212 |
$20,885,298 |
| Total People Bought |
2 |
2 |
5 |
8 |
| Total Buy Transactions |
3 |
3 |
7 |
16 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  William Arsani |
Director |
– • – |
2021-03-30 |
4/A |
A |
$0.00 |
$0 |
I/I |
2,032,501 |
814,874 |
|
- |
|
| William Arsani |
Director |
– • – |
2021-03-30 |
4 |
B |
$20.00 |
$14,000,000 |
I/I |
700,000 |
2,732,501 |
2.1 |
- |
|
| William Arsani |
Director |
– • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,032,501 |
2,032,501 |
|
- |
|
| Thacker Justin |
Vice President, Finance |
• – – |
2021-03-30 |
4 |
B |
$20.00 |
$350,000 |
D/D |
17,500 |
17,500 |
2.74 |
- |
|
| Jeffries Sean |
Chief Operating Officer |
• – – |
2021-03-30 |
4 |
B |
$20.00 |
$61,000 |
I/I |
3,050 |
3,050 |
1.99 |
- |
|
| Cormorant Private Healthcare Fund Iii Lp |
Former 10% Owner |
– – – |
2021-03-30 |
4 |
B |
$20.00 |
$15,000,000 |
I/I |
750,000 |
5,114,844 |
0.01 |
- |
|
| Cormorant Private Healthcare Fund Iii Lp |
Former 10% Owner |
– – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,364,844 |
4,364,844 |
|
- |
|
| George Simeon |
Director |
– • • |
2021-03-30 |
4 |
B |
$20.00 |
$5,000,000 |
I/I |
250,000 |
5,626,476 |
2.25 |
- |
|
| George Simeon |
Director |
– • • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5,376,476 |
5,376,476 |
|
- |
|
| Xu Stella |
Director |
– • • |
2021-03-30 |
4 |
B |
$20.00 |
$200,000 |
I/I |
10,000 |
4,730,830 |
2.25 |
- |
|
| Xu Stella |
Director |
– • • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,720,830 |
4,720,830 |
|
- |
|
| Quan Venture Fund Ii, L.p. |
10% Owner |
– – • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,720,830 |
4,720,830 |
|
- |
|
| Sr One Capital Management, Llc |
10% Owner |
– – • |
2021-03-30 |
4 |
B |
$20.00 |
$5,000,000 |
D/D |
250,000 |
5,626,476 |
2.45 |
- |
|
| Sr One Capital Management, Llc |
10% Owner |
– – • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,376,476 |
5,376,476 |
|
- |
|
| Lappe Rodney W |
Director |
– • – |
2021-03-30 |
4 |
B |
$20.00 |
$100,000 |
D/D |
5,000 |
97,024 |
2.39 |
- |
|
| Shah Pratik |
Executive Chairperson |
• • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
104,923 |
129,923 |
|
- |
|
| Shah Pratik |
Executive Chairperson |
• • – |
2021-03-30 |
4 |
B |
$20.00 |
$500,000 |
D/D |
25,000 |
25,000 |
2.81 |
- |
|
| Star Irrevocable Trust #1 Dated April 22, 2019 |
10% Owner |
– – • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,834,355 |
|
- |
|
| Jeffries Sean |
Chief Operating OfficerOfficer |
• – – |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
807,233 |
|
- |
|
| Ansari Aseem Z. |
10% Owner |
– – • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,668,711 |
|
- |
|
| Lappe Rodney W |
Director |
– • – |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
92,024 |
|
- |
|
| Siffert Joao Md |
President and CEOOfficer |
• • – |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
122,699 |
|
- |
|
| Light Irrevocable Trust #1 Dated April 22, 2019 |
10% Owner |
– – • |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,834,355 |
|
- |
|
| Schmid John P. |
Director |
– • – |
2021-03-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,674 |
|
- |
|
49 Records found
|
|
Page 2 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
